9/30/2022: Acknowledgments. The authors thank all
Post# of 148154
(Total Views: 762)
Posted On: 04/14/2024 2:33:01 AM
9/30/2022: Acknowledgments. The authors thank all of the study participants and their families and caregivers for participating in this trial. They are thankful for the contributions of the investigators and their dedicated staff. Editorial assistance was provided under the supervision of the authors by Neil Buss, PhD, from Medical Expressions, which was funded by CytoDyn.
Financial support. This work was supported by CytoDyn Inc. S. G. H. reports that this support included a sponsored research agreement between the Oregon Health & Science University and CytoDyn (fee for service work to perform C-C chemokine receptor 5 receptor occupancy assay).
https://academic.oup.com/cid/article/75/7/123...ogin=false
________________
It was Neil Buss supportive speaking with Dr. J @ tge end of the NIH video meeting. Dr. J also thanked him for 30 yrs of friendship.
https://m.youtube.com/watch?v=_x5aQ1rK7-M&...h=MTc4NDI0
Dr. Buss is from Roche.
Just fyi for putting a "face" to the voice.
& Oregon Health is from Cytodyn's HIV work.
Financial support. This work was supported by CytoDyn Inc. S. G. H. reports that this support included a sponsored research agreement between the Oregon Health & Science University and CytoDyn (fee for service work to perform C-C chemokine receptor 5 receptor occupancy assay).
https://academic.oup.com/cid/article/75/7/123...ogin=false
________________
It was Neil Buss supportive speaking with Dr. J @ tge end of the NIH video meeting. Dr. J also thanked him for 30 yrs of friendship.
https://m.youtube.com/watch?v=_x5aQ1rK7-M&...h=MTc4NDI0
Dr. Buss is from Roche.
Just fyi for putting a "face" to the voice.
& Oregon Health is from Cytodyn's HIV work.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼